Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.07
SHDMF's Cash to Debt is ranked lower than
54% of the 484 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.83 vs. SHDMF: 0.07 )
SHDMF' s 10-Year Cash to Debt Range
Min: 0.01   Max: 0.11
Current: 0.07

0.01
0.11
Equity to Asset 0.59
SHDMF's Equity to Asset is ranked higher than
82% of the 482 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.46 vs. SHDMF: 0.59 )
SHDMF' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.59
Current: 0.59

0.3
0.59
Interest Coverage 16.29
SHDMF's Interest Coverage is ranked higher than
68% of the 359 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.64 vs. SHDMF: 16.29 )
SHDMF' s 10-Year Interest Coverage Range
Min: 1.48   Max: 16.29
Current: 16.29

1.48
16.29
F-Score: 6
Z-Score: 4.84
M-Score: -2.42
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 7.80
SHDMF's Operating margin (%) is ranked higher than
92% of the 486 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.80 vs. SHDMF: 7.80 )
SHDMF' s 10-Year Operating margin (%) Range
Min: 7.8   Max: 11.03
Current: 7.8

7.8
11.03
Net-margin (%) 5.44
SHDMF's Net-margin (%) is ranked higher than
92% of the 486 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.37 vs. SHDMF: 5.44 )
SHDMF' s 10-Year Net-margin (%) Range
Min: 0.5   Max: 5.88
Current: 5.44

0.5
5.88
ROE (%) 13.32
SHDMF's ROE (%) is ranked higher than
85% of the 477 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 9.99 vs. SHDMF: 13.32 )
SHDMF' s 10-Year ROE (%) Range
Min: 1.65   Max: 16.2
Current: 13.32

1.65
16.2
ROA (%) 7.89
SHDMF's ROA (%) is ranked higher than
90% of the 485 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.42 vs. SHDMF: 7.89 )
SHDMF' s 10-Year ROA (%) Range
Min: 0.53   Max: 8.75
Current: 7.89

0.53
8.75
ROC (Joel Greenblatt) (%) 29.00
SHDMF's ROC (Joel Greenblatt) (%) is ranked higher than
85% of the 485 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.02 vs. SHDMF: 29.00 )
SHDMF' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 29   Max: 100.16
Current: 29

29
100.16
Revenue Growth (%) 5.40
SHDMF's Revenue Growth (%) is ranked higher than
77% of the 330 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.90 vs. SHDMF: 5.40 )
SHDMF' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 68.9
Current: 5.4

0
68.9
EBITDA Growth (%) 2.90
SHDMF's EBITDA Growth (%) is ranked higher than
74% of the 298 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.00 vs. SHDMF: 2.90 )
SHDMF' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 54.3
Current: 2.9

0
54.3
EPS Growth (%) 3.20
SHDMF's EPS Growth (%) is ranked higher than
75% of the 297 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.60 vs. SHDMF: 3.20 )
SHDMF' s 10-Year EPS Growth (%) Range
Min: 0   Max: 229.4
Current: 3.2

0
229.4
» SHDMF's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with SHDMF



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 20.40
SHDMF's P/E(ttm) is ranked higher than
60% of the 432 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 18.80 vs. SHDMF: 20.40 )
SHDMF' s 10-Year P/E(ttm) Range
Min: 11.76   Max: 29.9
Current: 20.4

11.76
29.9
P/B 2.71
SHDMF's P/B is ranked higher than
50% of the 470 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.69 vs. SHDMF: 2.71 )
SHDMF' s 10-Year P/B Range
Min: 1.8   Max: 4.41
Current: 2.71

1.8
4.41
P/S 1.11
SHDMF's P/S is ranked lower than
62% of the 492 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.46 vs. SHDMF: 1.11 )
SHDMF' s 10-Year P/S Range
Min: 0.71   Max: 1.57
Current: 1.11

0.71
1.57
PFCF 26.22
SHDMF's PFCF is ranked higher than
58% of the 298 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 21.90 vs. SHDMF: 26.22 )
SHDMF' s 10-Year PFCF Range
Min: 13.98   Max: 896.2
Current: 26.22

13.98
896.2
EV-to-EBIT 15.21
SHDMF's EV-to-EBIT is ranked higher than
54% of the 455 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 13.70 vs. SHDMF: 15.21 )
SHDMF' s 10-Year EV-to-EBIT Range
Min: 9.2   Max: 21.3
Current: 15.21

9.2
21.3
PEG 5.50
SHDMF's PEG is ranked higher than
50% of the 240 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.21 vs. SHDMF: 5.50 )
SHDMF' s 10-Year PEG Range
Min: 0.98   Max: 31.47
Current: 5.5

0.98
31.47
Shiller P/E 20.90
SHDMF's Shiller P/E is ranked higher than
65% of the 235 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.05 vs. SHDMF: 20.90 )
SHDMF' s 10-Year Shiller P/E Range
Min: 14.22   Max: 33.95
Current: 20.9

14.22
33.95

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.93
SHDMF's Dividend Yield is ranked higher than
55% of the 408 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.87 vs. SHDMF: 1.93 )
SHDMF' s 10-Year Dividend Yield Range
Min: 0.24   Max: 2.67
Current: 1.93

0.24
2.67
Dividend Payout 0.40
SHDMF's Dividend Payout is ranked higher than
59% of the 361 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.33 vs. SHDMF: 0.40 )
SHDMF' s 10-Year Dividend Payout Range
Min: 0.24   Max: 0.38
Current: 0.4

0.24
0.38
Dividend growth (3y) 8.20
SHDMF's Dividend growth (3y) is ranked higher than
84% of the 231 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.80 vs. SHDMF: 8.20 )
SHDMF' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 29.1
Current: 8.2

0
29.1
Yield on cost (5-Year) 2.77
SHDMF's Yield on cost (5-Year) is ranked higher than
64% of the 415 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.06 vs. SHDMF: 2.77 )
SHDMF' s 10-Year Yield on cost (5-Year) Range
Min: 0.34   Max: 3.83
Current: 2.77

0.34
3.83
Share Buyback Rate 2.50
SHDMF's Share Buyback Rate is ranked higher than
91% of the 271 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.10 vs. SHDMF: 2.50 )
SHDMF' s 10-Year Share Buyback Rate Range
Min: 0   Max: -0.4
Current: 2.5

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 7.80
SHDMF's Price/Tangible Book is ranked lower than
69% of the 412 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.20 vs. SHDMF: 7.80 )
SHDMF' s 10-Year Price/Tangible Book Range
Min: 5.96   Max: 109.62
Current: 7.8

5.96
109.62
Price/DCF (Projected) 1.70
SHDMF's Price/DCF (Projected) is ranked higher than
56% of the 238 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.30 vs. SHDMF: 1.70 )
SHDMF' s 10-Year Price/DCF (Projected) Range
Min: 1.42   Max: 2.19
Current: 1.7

1.42
2.19
Price/Median PS Value 0.90
SHDMF's Price/Median PS Value is ranked higher than
81% of the 456 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.10 vs. SHDMF: 0.90 )
SHDMF' s 10-Year Price/Median PS Value Range
Min: 0.7   Max: 1.23
Current: 0.9

0.7
1.23
Price/Graham Number 2.60
SHDMF's Price/Graham Number is ranked lower than
61% of the 380 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.42 vs. SHDMF: 2.60 )
SHDMF' s 10-Year Price/Graham Number Range
Min: 2   Max: 11.29
Current: 2.6

2
11.29
Earnings Yield (Greenblatt) 6.60
SHDMF's Earnings Yield (Greenblatt) is ranked higher than
60% of the 466 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.30 vs. SHDMF: 6.60 )
SHDMF' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.7   Max: 10.9
Current: 6.6

4.7
10.9
Forward Rate of Return (Yacktman) 3.51
SHDMF's Forward Rate of Return (Yacktman) is ranked higher than
67% of the 279 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 9.91 vs. SHDMF: 3.51 )
SHDMF' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 2.8   Max: 20.5
Current: 3.51

2.8
20.5

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare: » details
Traded in other countries:SC.Canada, SDZ.Germany
Shoppers Drug Mart Corporation was founded in 1962. The Company is the licensor of full-service retail drug stores operating under the name Shoppers Drug Mart (Pharmaprix in Québec). The stores are owned and operated by the Company's licensed Associate-owners who have helped build a brand that is synonymous with exceptional service, value and trust. The Company also licenses or owns more than 55 medical clinic pharmacies operating under the name Shoppers Simply Pharmacy (Pharmaprix Simplement Santé in Québec) and six luxury beauty destinations operating as Murale. The Company owns and operates 62 Shoppers Home Health Care stores, which are engaged in the sale and service of assisted-living devices, medical equipment, home-care products and durable mobility equipment to institutional and retail customers. In addition to its retail store network, the Company owns Shoppers Drug Mart Specialty Health Network Inc., a provider of specialty drug distribution, pharmacy and comprehensive patient support services, and MediSystem Technologies Inc., a provider of pharmaceutical products and services to long-term care facilities.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide